Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could "represent a paradigm shift" in virus treatment, according to the university. Read more
Kxan - Dec 26
MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibod... Read more
Medical News - Dec 18
Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable populations, including people with compromised immune systems. According to the Centers for Disease Co... Read more
Medical News - Dec 18
The genome differs from person to person in thousands of positions. In some cases, this means that proteins have a different building block in certain regions, rendering some antibody-based therapies ineffective, report researchers from the University of Basel, Switzerland. Read more
Medical News - Dec 18
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies. Read more
Medical News - Dec 05
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment. Read more
Medical News - Nov 22
The U.S. Food and Drug Administration (FDA) on Friday said it has received postmarketing reports of neutralizing antibodies to ADAMTS13 in patients treated with Adzynma (recombinant ADAMTS13), including one pediatric death.Takeda Pharmaceutical Co., Ltd. (NYSE:TAK) Adzynma is approved as a prophy... Read more
Benzinga - Nov 21
The global human combinatorial antibody libraries market size is calculated at USD 122 million in 2025 and is expected to reach around USD 189.57 million by 2034, growing at a CAGR of 5.04% for the forecasted period. The global human combinatorial antibody libraries market size is calculated at U... Read more
Globenewswire_fr - Oct 24
The newly developed antibody offers new hope to cancer patients Read more
Mirror - Oct 23
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents-antibody-drug conjugates (ADCs)-can dramatically improve outcomes for patients with early-stage HER2-positive breast cancer. Read more
Medical News - Oct 19
